This report studies the global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) market size, industry status and forecast, competition landscape and growth opportunity. This research report categorizes the global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) market by companies, region, type and end-use industry.
Request A Sample Copy of This Report at: https://bit.ly/2JCml2a
Circulating tumor cells (CTCs) are tumor cells that detach from the primary tumor and travel in the bloodstream, spreading from the original tumor to other locations, leading to cancer metastasis. These cells exist in peripheral blood of cancer patients and detection of CTCs can help to determine the process of metastasis. In contrast with other blood cells, the number of CTCs is very rare in blood which makes them difficult to detect.
Cancer stem cells (CSCs) are cancer cells that have all the classical properties of normal stem cells. Specifically, they are able to both give rise to more copies of themselves and to give rise to all cell types found in the cancer.
According to the research, the most potential market in the main countries of circulating tumor cells (CTCs) and cancer stem cells (CSCs) industry is China, determined by the rising level of medical care. Besides, South America, Asia-Pacific should also be focused by the investors. They are the potential consumers of circulating tumor cells (CTCs) and cancer stem cells (CSCs).
The CellSearch test is the only FDA-approved test for CTC assessment. For the moment, the products are not comprehensive, and technologies are not stable.
Morbidity and mortality rate of cancer is rising at a faster speed worldwide and thus prevention of cancer and cancer treatment is grabbing attention of cancer researchers globally. Stem cells and cell therapy have shown significant potential to treat cancer effectively.
In 2017, the global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) market size was 6420 million US$ and it is expected to reach 30200 million US$ by the end of 2025, with a CAGR of 21.4% during 2018-2025.
Browse Full Research Report with TOC on https://bit.ly/2l6aKy1
This report focuses on the global top players, covered
• Janssen
• Qiagen
• Advanced Cell Diagnostics
• ApoCell
• Biofluidica
• Clearbridge Biomedics
• CytoTrack
• Celsee
• Fluxion
• Gilupi
• Cynvenio
• On-chip
• YZY Bio
• BioView
• Fluidigm
• Ikonisys
• AdnaGen
• IVDiagnostics
• Miltenyi Biotec
• ScreenCell
• Silicon Biosystems
Market segment by Regions/Countries, this report covers
• United States
• Europe
• China
• Japan
• Southeast Asia
• India
Market segment by Type, the product can be split into
• CellSearch
• Others
Market segment by Application, split into
• Breast Cancer Diagnosis and Treatment
• Prostate Cancer Diagnosis and Treatment
• Colorectal Cancer Diagnosis and Treatment
• Lung Cancer Diagnosis and Treatment
• Other Cancers Diagnosis and Treatment
The study objectives of this report are:
• To study and forecast the market size of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) in global market.
• To analyze the global key players, SWOT analysis, value and global market share for top players.
• To define, describe and forecast the market by type, end use and region.
• To analyze and compare the market status and forecast between China and major regions, namely, United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
• To analyze the global key regions market potential and advantage, opportunity and challenge, restraints and risks.
• To identify significant trends and factors driving or inhibiting the market growth.
• To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
• To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
• To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
• To strategically profile the key players and comprehensively analyze their growth strategies.
In this study, the years considered to estimate the market size of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) are as follows:
• History Year: 2013-2017
• Base Year: 2017
• Estimated Year: 2018
• Forecast Year 2018 to 2025
For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Key Stakeholders
• Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Manufacturers
• Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Distributors/Traders/Wholesalers
• Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Subcomponent Manufacturers
• Industry Association
• Downstream Vendors
Available Customizations
• With the given market data, QYResearch offers customizations according to the company's specific needs. The following customization options are available for the report:
• Regional and country-level analysis of the Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) market, by end-use.
• Detailed analysis and profiles of additional market players.
About Radiant Insights
Radiant Insights is a platform for companies looking to meet their market research and business intelligence requirements. We assist and facilitate organizations and individuals procure market research reports, helping them in the decision making process. We have a comprehensive collection of reports, covering over 40 key industries and a host of micro markets. In addition to over extensive database of reports, our experienced research coordinators also offer a host of ancillary services such as, research partnerships/ tie-ups and customized research solutions.
Media Contact:
Michelle Thoras
201 Spear Street 1100,
Suite 3036, San Francisco,
CA 94105, United States
Tel: 1-415-349-0054
Toll Free: 1-888-928-9744
Mail: [email protected]